Veterynarna biotehnologija – Veterinary biotechnology, 2016, 29, 34-42 [in Ukrainian].
BABKINA M.M., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it., TARASOV O.A., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Institute of Veterinary Medicine of the NAAS
PALCHYKOVSKA L.G., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it., VASYLCHENKO O.V., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Institute of Molecular Biology and Genetics of the NAS of Ukraine
DERIABIN O.M., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
State Scientific Control Institute of Biotechnology and Strains of Microorganisms
DETERMINATION OF ANTIBACTERIAL ACTIVITY OF TRHEECYCLIC TRIAZINES AGAINST KLEBSIELLA PNEUMONIAE
Introduction. Nowadays the important task for scientists is to intensify search for new compounds with antimicrobial activity of different chemical classes what can be used as a base for creating new antimicrobial drugs. The results suggest that a way to search the new perspective and approaches to the development of innovative synthetic drugs lies in the field of analysis of newly synthesized compounds.
The goal of the work was to study antibacterial properties of substances of threecyclic triazines class compounds towards Klebsiella pneumoniae.
Materials and methods. In this work it was used the substances of class of threecyclic triazines and Klebsiella pneumoniae pathogen. In the research disco-diffusion method and method of serial microdilution were used.
Results of research and discussion. It was detected that threecyclic triazines had sufficient activity against Klebsiella pneumoniae. The most active among the tested substances were compounds ODI-44, ODI-45, ODI-46, ODI-48 and ODI-57 with MIC 0.0041 mg/cm3 and growth inhibition zone from 23±0.36 mm to 24.6±0.21 mm.
Conclusion and prospects for further research: 1. It was revealed that chemical compounds of treecyclic triazines showed antimicrobial activity against Klebsiella pneumoniae. 2. The most promising compounds are ODI-44 (3-oxo-2,3-dihydro-1H-[1,2,4]triazino[5,6-b][1,4]benzothiazine-7-carboxylic acid), ODI-45 (7-methyl-3-oxo-2,3-dihydro-1H-[1,2,4]triazino[5,6-b][1,4]benzothiazine-9-carboxylic acid), ODI-46 (2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrimido[4,5-b][1,4]benzothiazine-7-carboxylic acid), ODI-48 (3-(dimethylamino)-2H-[1,2,4]triazino[6,5-b][1,4]benzothiazine-8-carboxylic acid) and ODI-57(7-methyl-3-oxo-N-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-[1,2,4]triazino[5,6-b][1,4]benzothiazine-9-carboxamide) and they can be considered as a candidates for future research.
Keywords: antibacterial activity, threecyclic triazines, Klebsiella pneumoniae, minimal inhibitory concentration, zones of growth inhibition.
REFERENCES
- Dorofeev, K.A. (1961). Klebsielly i klebsielezy [Klebsiella’s and klebsiellesis]. Kirovskii sel’skokhoziaistvennyi institute. – Kirov’s agricultures institute [in Russian].
- Kablukova, E.K., Dergileva, M.P. & Tsvik, M.V. (1988). Osobennosti techeniya enterokolitov vizvannih enterobacteriyamii, v sochitanii s ostroi virusnoi infekciej [Features flow enterocolitics caused by opportunistic enterobacteria, in combination with an acute viral infection]. Kishechnie infekcii – Intestinal infections, 20, 63-65 [in Russian].
- Bukholm, G., Bergh, M. & Degré, M. (1988). Hep-2 cells alters the adhesive ability of Pseudomonas aeruginosa. APMIS, 96 (11), 1043–1048.
- Mahtab, A. (1985). Isolation and characterization of antibiotic resistant bacterial strains from clinical isolates. Indian J. Microbiol., 25, № 3–4, 118–124.
- Doyle, M.P. (2006). Antimicrobial resistance: implications for the food system. Compr. Rev. Food Sci. Food Saf., 5, 71–137.
- Yeh, P.J., Hegreness, M.J., Aiden, A.P. & Kishnov, R. (2009). Drug interactions and the evolution of antibiotic resistance. Nat. Rev. Microbiol., 5, 460–466.
- Lenski, R.E., Chadwick, D.J. & Goode, J. (1997). The cost of antibiotic resistance – from the perspective of bacterium. Antibiotic Resistance: Origins, Evolution, Selection and Spread Chichester: Wiley and Sons., 131–151.
- Petkovic, H., Cullum, J., Hranueli, D., Hunter, I.S., & Peric-Concha, N. et all. (2006). Genetics of Streptomyces rimosus, the oxytetracycline producer. Microbiol. Mol. Biol. Rev., 70, 704–728.
- Benveniste, R. & Daves, J. (1973). Amynoglycoside antibiotic-invactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistance bacteria. Proc. Natl. Acad. Svi. USA, 70, 2276–2280.
- Rita R., Colwell. & Jonathan, A. Patz. (1994). Climate, Infectious Disease and Health: An Interdisciplinary Perspective. The Society. – Retrieved from: http://www.asm.org/ASM/files/CCPAGECONTENT/DOCFILENAME/000005962/ antibiot%5B1%.
- Yakovlev, V.P. & Yakovlev, S.V. (2002). Perspectivu sozdaniya i vnedreniya novukh antimicrobnikh preparatov [Prospects for the creation and introduction of new antimicrobial preparations]. Inf. antimicrob. terapija – Inf. antimicrob. therapy, 4 (2), 24–30 [in Russian].
- Devasahayam, G., Scheld, W.M. & Hoffman, P.S. (2010). Newer antibacterial drugs for a new century. Expert Opin. Investig. Drugs, 19, 215–234.
- Britsun, V.M. & Maiboroda, O.I. (2010). Antimicrobni vlastivosti 2-aril-2,3,-dihidro-4n-[1,3]tiazino[3,2-ά]benzimidazol-4-oniv ta ikh pohidnikh [Antimicrobial properties of 2-aryl-2,3-dihydro-4n-[1,3]tiazyno[3,2-ά]benzimidazole-4-ones and their derivatives]. Processing from Pharmacy of Ukraine. Future Outlook: Materialyi VII Natsionalʼnogo zʼizdy farmacevtiv (15-17 veresnya 2010 roky) – Materials of VII National Congress of Pharmacists. (pp 20). Kharkiv: NPhaY [in Ukraine].
- Opredelenie chuvstvitel’nosti microorganizmov k antibacterial’nym preparatam [Determination of the susceptibility of microorganisms to antimicrobial agents]. (2004). Manual. Moscow: Federal’nyi tsentr gossanepidnadzora Minzdrava Rosii [in Russian].
Download full text in PDF